metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Anal Squamous Cell Carcinoma in Chronic Severe Perianal Crohn's Disease
Información de la revista
Vol. 94. Núm. 3.
Páginas 198-200 (marzo 2016)
Vol. 94. Núm. 3.
Páginas 198-200 (marzo 2016)
Scientific letter
Acceso a texto completo
Anal Squamous Cell Carcinoma in Chronic Severe Perianal Crohn's Disease
Carcinoma escamoso de ano en enfermedad de Crohn perianal severa de larga evolución
Visitas
10083
María Arana de la Torre
Autor para correspondencia
mdcina@yahoo.es

Corresponding author.
, Fernando Jiménez Escovar, José María García González, Irene Alvarez Abad, Alberto Colina Alonso
Servicio de Cirugía General y del Aparato Digestivo, Hospital de Cruces, Baracaldo, Vizcaya, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (2)
Texto completo

Crohn's disease is a chronic, recurrent, inflammatory bowel disease. One of its most frequent manifestations is active perianal fistula, which can lead to severe perianal sepsis.

Although the appearance of squamous carcinoma over a fistula in perianal Crohn's is extremely rare, its development could be due to the cellular stimulus associated with chronic suppuration, immunosuppression or the use of anti-TNF.1

We present the case of a 59-year-old male, who was a smoker and had had Crohn's disease for 25 years, with no extraintestinal manifestations, and fistulising ileocolic involvement, associated with perianal disease. The patient's progress was torpid and several hospitalisations were necessary: ileocecal resection (1990), perianal abscess (1996), right hemicolectomy (2000), perianal abscess and fistulotomy (2003). Since the onset of the disease, the patient had been intermittently treated with antibiotics, mesalazine, azathioprine and corticosteroids. Furthermore, in 2007 the patient presented a melanoma in the left thigh that was treated with interferon, surgery and radiotherapy.

After commencing treatment with interferon, the patient reported worsened abdominal and perineal symptoms. In 2008, he presented severe perianal recurrence that did not respond to conservative treatment and required drainage as well as debridement of 3 fistula tracts (Fig. 1). At this time, the patient was referred to our hospital.

Fig. 1.

Perianal sepsis secondary to Crohn's disease.

(0.13MB).

Examination revealed inflammation, perianal and gluteal cellulitis, purulent drainage with compression of the abscess cavities and multiple fistulous openings, together with extensive perianal scar tissue.

Complimentary tests showed evidence of marked destructuring of the sphincter apparatus, a large perianal collection (2cm×4.5cm×10cm) extending to the right ischiorectal fossa, left pararectal and intergluteal folds, 2 large fistulous tracts on both sides of the anal canal to the supralevator region, proctitis, and important inflammatory changes in the perirectal fat, perianal and intergluteal regions.

Given these findings, we decided to operate in order to control the perianal sepsis with extensive cutaneous debridement and immediate drainage of the abscess cavities. The fistulous tracts were identified and redirected, partial fistulectomy was done of the secondary tracts, followed by a lateral diverting colostomy (Fig. 2). Biopsies were taken. The pathology study reported keratinizing squamous-cell carcinoma over a fistulous tract in the left perianal region, although the precise invasion type could not be specified, so we decided to proceed with abdominoperineal amputation.

Fig. 2.

Squamous carcinoma of the anus developed over perianal Crohn's disease.

(0.09MB).

The pathology study reported transmural inflammation with mucosal ulcerations, moderate glandular epithelial dysplasia in the rectum and keratinizing squamous-cell carcinoma, excrescent and infiltrating the perianal tissue without affecting the rectal wall. The resection margins of the surgical specimen had a very high probability for involvement.

During this same hospitalization period, a recurrence of the cutaneous melanoma was once again removed by the Plastic Surgery Unit.

Due to the high probability of residual tumour in the surgical margins and the inability for complete exeresis, palliative radiotherapy was initiated. Nonetheless, a bleeding, ulcerated and papilliform lesion developed in the perineum, which measured 8cm×3cm×6cm. The pathology study of the lesion was compatible with carcinoma relapse. The lesion progressed and fistulised to the small bowel; the patient died a few days later.

The incidence of anorectal fistulas in Crohn's disease is from 20 to 25% and reaches 60% in rectal Crohn's. Due to the nature of the disease and its difficult treatment, these fistulas can become chronic.2 Chronic disease is a predisposing factor for stenosis, sphincter destruction and even malignant transformation. Delayed diagnosis of malignancy is frequent, as the symptoms are usually attributed to the fistula and biopsy samples may be taken later on.1,3 In practice, anal examination under anaesthesia, endoanal ultrasound and magnetic resonance provide adequate assessment.

Perineal sepsis is the most severe complication of acute perianal disease. It requires intensive treatment using antibiotic therapy, immediate drainage of the abscess cavities and, frequently, prolonged use of drainage setons. If perianal sepsis progresses, a diverting stoma or even proctectomy can be required.

Anal canal carcinoma is an uncommon disease, and squamous carcinoma is the usual histological variety.4 Two very important aetiological factors involved in their development are human papilloma virus infection and chronic immunosuppression.

Symptoms are nonspecific; therefore, a high rate of suspicion is required, as well as a complete exploration and biopsy of any doubtful lesion.

Chemo-radiotherapy is the standard treatment of invasive carcinoma of the anus.5 Early-stage lesions (T1) should be evaluated for initial surgical treatment. The rate of complete response with chemoradiotherapy is 75%, and the overall 5-year survival rate is 66%.

The appearance of a squamous-cell carcinoma over a fistula due to perianal Crohn's disease, as in our patient, is extremely rare (0.7%).6,7 The causal relationship is unknown (probable influence of constant cellular regeneration and the state of immunosuppression).1,8

Treatment is the same as for squamous carcinoma of the anal canal, involving chemotherapy, radiotherapy or surgery, with a poorer prognosis as it develops on inflammatory tissue.6,9,10

Conflict of Interest

None.

References
[1]
K.W. Somerville, M.J. Langman, D.J. da Cruz, T.W. Balfour, L. Sully.
Malignant transformation of anal skin tags in Crohn's disease.
Gut, 25 (1984), pp. 1124-1125
[2]
R. Sordo-Mejia, W.B. Gaertner.
Multidisciplinary and evidence-based management of fistulizing perianal Crohn's disease.
World J Gastrointest Pathophysiol, 5 (2014), pp. 239-251
[3]
B. Benjelloun el, M. Abkari, A. Ousadden, K. Ait Taleb.
Squamous cell carcinoma associated anal fístulas in Crohn's disease unique case report with literature review.
J Crohns Colitis, 7 (2013), pp. e232-e235
[4]
J.V. Klas, D.A. Rothenberger, W.D. Wong, R.D. Madoff.
Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.
Cancer, 85 (1999), pp. 1686-1693
[5]
J. Peron, O. Bylicki, C. Laude, I. Martel-Lafay, C. Carrie, S. Racadot.
Nonoperative management of squamous-cell carcinoma of the rectum.
Dis Colon Rectum, 58 (2015), pp. 60-64
[6]
A. Ky, N. Sohn, M.A. Weinstein, B.I. Korelitz.
Carcinoma arising in anorectal fístulas of Crohn's disease.
Dis Colon Rectum, 41 (1998), pp. 992-996
[7]
A.A. Slesser, A. Bhangu, M. Bower, R. Goldin, P.P. Tekkis.
A systematic review of anal squamous cell carcinoma in inflammatory bowel disease.
Surg Oncol, 22 (2013), pp. 230-237
[8]
A.M. Bahadursingh, W.E. Longo.
Malignant transformation of chronic perianal Crohn's fístula.
Am J Surg, 189 (2005), pp. 61-62
[9]
J. Tolmos, H.I. Vargas, S. Lim, M. Stamos.
A forty-year experience with anal carcinoma: Changing trends and impact of multimodality therapy.
Am Surg, 63 (1997), pp. 918-922
[10]
J.P. Gerard, L. Ayzac, D. Hun, P. Romestaing, R. Coquard, J.M. Ardiet, et al.
Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients.
Radiother Oncol, 46 (1998), pp. 249-256

Please cite this article as: Arana de la Torre M, Jiménez Escovar F, García González JM, Alvarez Abad I, Colina Alonso A. Carcinoma escamoso de ano en enfermedad de Crohn perianal severa de larga evolución. Cir Esp. 2016;94:198–200.

Copyright © 2014. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos